Medtronic plc, a global leader in healthcare technology, announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management. The acqu…
Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare sector, is proud to announce the successful acquisition of CeeNU (Lomustine) from Bristol Myers Squibb, Canada as of June 29th, 2026. This strategic acquisition marks a significant milestone in Septa's ongoing expansion and underscores its…
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced a multi-target strategic alliance with Bora Pharmaceuticals Co., Ltd, a global leader in pharmaceutical manufacturing. The proposed alliance will be governed by definitive agreements to be discussed an…
Charles River Laboratories International, Inc. announced a collaboration with Arovella Therapeutics Ltd, a biotechnology company, to provide Good Manufacturing Practice (GMP) Next Generation Sequencing (NGS) services for cell characterization. The collaboration helps Arovella achieve its goal of creating a unique Inva…
Novartis announced that it has entered into an agreement to acquire Myricx Bio, a privately held UK-based biotechnology company developing a new class of antibody-drug conjugates (ADCs), using N-myristoyltransferase inhibitor (NMTi) payloads. The proposed acquisition would strengthen the Novartis oncology pipeline an…
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, and Nanoscope Therapeutics, a biotechnology company committed to commercializing novel, disease-agnostic, vision-restoring therapies for patients with photoreceptor loss due to retinal degeneration, announced an ex…
Resmed, the leading health technology company focused on sleep, breathing and care delivered in the home, announced it has entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused exclusively on health care. This move reflects Resmed’s 2030 stra…
Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility. Over the next five years, the company will invest US$100 million to modernize key equipment – including 100 m³ reactors and other critical systems – enhancing reliability, enabling great…
OTR Therapeutics, a clinical-stage biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, announced that it has entered into a strategic collaboration agreement with LG Chem, a leading global company that specializes in life sciences as one of its core businesses. Th…
Helix, the leading enterprise genomics company, announced a multi-year relationship with AstraZeneca, a global biopharmaceutical company. Under this agreement AstraZeneca will gain access to Helix's continuously growing, deeply phenotyped GenoSphere™ cohorts that cover a wide range of disease areas. "Our collaborati…
Page 6 of 40